A test measuring proteins in spinal fluid may help support the diagnosis of MS, especially in patients whose disease is harder to diagnose.

A protein best known for its role in Parkinson’s disease can accelerate Alzheimer’s-related brain changes by up to 20 times in patients who carry elevated levels of both pathologies, according to new ...

Doctors are increasingly using proteins in spinal fluid to support the diagnosis of Alzheimer’s disease and other brain disorders. Our research shows that each person has a characteristic background ...

Fighting Alzheimer’s disease is a race against time. By the time most patients are diagnosed and treated, their cognitive symptoms have already advanced significantly. New research, though, pinpoints ...

Some scientists believe that toxic tau fibrils hop between synapses to spread throughout the brain, prompted by Aβ aggregates and overactive neurons. New imaging and biomarker data add weight to this ...

Proteins floating in the cerebrospinal fluid might do more than diagnose Alzheimer’s disease—they may identify different subtypes, according to researchers led by Betty Tijms of the Amsterdam ...

Summary: Women make up nearly two-thirds of Alzheimer’s patients, and researcher may have just discovered a massive reason why. A new study found that when the protein alpha-synuclein (typically ...